The World Health Organization is in active dialogue with the food, beverage, alcohol, and even sporting goods industries to encourage marketing changes and product formulations to help curb the growing worldwide prevalence of non-communicable diseases (NCDs).
In March 2013, a delegation led by the CSIS Global Health Policy Center traveled to Zambia to report on the opportunities and challenges of strengthening U.S. investments overseas in women’s health. This report comes at a timely and important moment; the U.S. government and its partners have an opportunity to build on the current momentum and incorporate lessons learned into the next phase of planning and implementation for Saving Mothers, Giving Life (SMGL), which addresses maternal mortality; and Pink Ribbon Red Ribbon (PRRR), which integrates cervical cancer screening and treatment with HIV/AIDS services and increases breast cancer awareness.
After 25 years of remarkable achievements and sometimes harrowing setbacks, a successful conclusion to global polio eradication could finally be within reach. Every effort should be made to capitalize on this promising moment: if we don't, the opportunity to eradicate polio may slip by.
Yesterday, the National Institute of Allergy and Infectious Diseases (NIAID) of the U.S. National Institutes of Health (NIH) announced that it was stopping further testing of a candidate HIV vaccine combination (study HVTN 505). While this is a disappointing turn of events, perseverance is needed.
While the giant PEPFAR program to fight HIV/AIDS in developing countries gets a lot of attention in U.S. foreign policy discussions, a lesser known initiative to address malaria is achieving sustained, impressive results. The President’s Malaria Initiative (PMI), launched in 2005 by former President Bush, helps a range of countries prevent and treat malaria by providing them with technical guidance, programmatic support, and funding. Its model and achievements over almost a decade offer important lessons.
With the release of our Global Health Policy in the Second Obama Term iTunes University course, we’ve received a few questions about how the course works. This is a quick 101 on the course’s basics.
On March 21, KNCV honored USAID for the agency’s contribution to the field of global TB control. Dr. Sharon Stash, Senior Fellow and Deputy Director at the Global Health Policy Center, spoke at the awards ceremony and noted options for how the U.S. government can advance these global efforts.
The U.S. Institute of Medicine at the National Academy of Sciences recently released a new report on Countering the Problem of Falsified and Substandard Drugs. Commissioned by the U.S. Food and Drug Administration, it raises important, indeed frightening, concerns about the quality and reliability of medicines in the U.S. and other developed nations, as well as in low- and middle-income countries that often have weaker capacities, and proposes concrete steps in response.
The Office of Global Health Diplomacy offers the Obama administration a second chance, after costly stumbles in the first term, to get its global health policy right, especially in improving cross-agency coherence of U.S. international health programs and sharpening the vision for U.S. leadership in global health.
The Seattle-based Institute for Health Metrics and Evaluation (IHME) recently published the most recent global estimates of disease burden that update the leading causes of death and disability across the world, based on data from 2010. It seems a devilishly complicated and ambitious endeavor. While a number of smart people have raised concerns about the reliability of the underlying data, the study report tells a powerful, compelling story about trends in mortality and disability.
In March 2012, the Peace Corps, the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), and the Global Health Service Corps launched the public-private Global Health Service Partnership, a promising initiative that could improve the health sector in a number of developing countries. The CSIS Global Health Policy Center was fortunate to have the opportunity to play a modest role during the planning stages of this innovative enterprise. As the Partnership moves forward, a number of potential concerns will require careful attention.
The U.S. Institute of Medicine of the National Academy of Sciences recently completed a congressionally-mandated impact evaluation of the PEPFAR HIV/AIDS program, which is the single largest ever health initiative of the U.S. government. The Global Fund needs to pore over the IOM evaluation and absorb its well-crafted recommendations for achieving even more in the future. Especially in lean economic times, our forward progress in fighting AIDS will depend more than ever on being smart about our approach.